Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Public ClinicalTrials.gov record NCT02032433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CTN-0051: Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment
Study identification
- NCT ID
- NCT02032433
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- NYU Langone Health
- Other
- Enrollment
- 570 participants
Conditions and interventions
Conditions
Interventions
- Extended-Release Naltrexone Drug
- Buprenorphine-Naloxone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 28, 2014
- Primary completion
- Jan 24, 2017
- Completion
- Jan 30, 2017
- Last update posted
- Aug 12, 2020
2014 – 2017
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tarzana Treatment Centers | Tarzana | California | 91356 | — |
| Gateway Community Services, Inc. | Jacksonville | Florida | 32201 | — |
| Avery Road Treatment Center | Rockville | Maryland | 20853 | — |
| Stanley Street Treatment and Resources | Fall River | Massachusetts | 02720 | — |
| Turquoise Lodge Hospital | Albuquerque | New Mexico | 87108 | — |
| Bellevue Hospital Center | New York | New York | 10016 | — |
| Maryhaven | Columbus | Ohio | 43207 | — |
| Evergreen Treatment Services | Seattle | Washington | 98134 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02032433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02032433 live on ClinicalTrials.gov.